Multi-Omic Profiling for Molecular Diagnosis of Erythrodermic Skin Diseases
Background Erythroderma is one of the most challenging clinical scenarios in modern dermatology. It represents an acute, potentially life-threatening inflammatory condition characterised by erythema and scaling affecting more than 90% of the skin surface, with mortality rates up to 9%. Various underlying skin diseases cause erythroderma yet are difficult to distinguish clinically and histopathologically. This poses a major diagnostic challenge and delays targeted therapy, with potentially severe acute and long-term consequences. Objectives To define disease-specific molecular programs in erythrodermic skin using integrated proteomics and transcriptomics, and to translate these into a diagnostic framework. Methods Here we performed mass spectrometry (MS) - based proteomics and RNA sequencing on formalin-fixed, paraffin-embedded skin biopsies from 96 patients with erythroderma caused by pityriasis rubra pilaris (PRP, n=19), psoriasis (n=18), atopic dermatitis (AD, n=20), cutaneous T-cell lymphoma (CTCL, n=18), drug-induced maculopapular rash (MPR, n=21), and 20 healthy skin controls. Samples from four independent centers were included and MS-based proteomics was acquired on the Orbitrap Astral mass spectrometer. We performed multi-omic data integration through multi-omics factor analysis (MOFA), and disease classification was achieved using the adaptive machine-learning framework ADAPT-Mx, benchmarked against blinded clinico-histopathological assessment. Results We quantified over 9,300 proteins and 17,200 protein-coding transcripts, revealing distinct molecular signatures for each disease. The proteome showed elevated expression of type-2 immunity-associated Charcot-Leyden crystal protein in AD, establishing a potential link between eosinophil-dominant inflammation and NLRP3 inflammasome activation. Transcriptomic analysis demonstrated selective upregulation of IL-17C in PRP, correlating strongly with IL-1 family cytokine expression. Notably, only a subset of PRP patients exhibited this signature, suggesting treatment-relevant disease endotypes. Multi-omic integration identified elevated expression of T-cell regulator RASAL3 in CTCL, not previously characterized in its pathogenesis. ADAPT-Mx, our machine-learning classifier, achieved 73.9% diagnostic accuracy in the held-out test cohort, outperforming conventional clinico-histopathological assessment (59.5%), with AUC values of 0.87–1.00 across disease entities. Conclusions This study provides an integrated multi-omic framework for inflammatory skin diseases, combining RNA sequencing with large-scale MS-based proteomics. By enabling per-sample classification without imputation, our workflow offers proof of concept for multi-omic-driven diagnosis that can support clinical decision-making across inflammatory skin diseases.
Authors
- Rudolf Stadler (ORCID: https://orcid.org/0000-0003-2683-6028)
- Anne-Sophie Boehm
- Thierry M. Nordmann (ORCID: https://orcid.org/0000-0002-3702-815X)
- Benjamin Kendziora (ORCID: https://orcid.org/0000-0002-5234-5380)
- Eva Maria Oppel (ORCID: https://orcid.org/0000-0002-8412-2667)
- Nora ASZODI
- Felix Lauffer (ORCID: https://orcid.org/0000-0002-1992-2836)
- Lars Einar French (ORCID: https://orcid.org/0000-0002-4629-1486)
- Laurie Eicher
- Pia‐Charlotte Stadler (ORCID: https://orcid.org/0000-0001-5892-4925)
- Benjamin Maximilian Clanner-Engelshofen (ORCID: https://orcid.org/0000-0001-9863-3380)
- Werner Kempf (ORCID: https://orcid.org/0000-0002-6552-8629)
- Nicholas Moellhoff (ORCID: https://orcid.org/0000-0002-1059-5840)
- Teodora Pumnea (ORCID: https://orcid.org/0000-0003-2596-8088)
- Georg Wallmann (ORCID: https://orcid.org/0000-0003-4749-3730)
- Anna Oschmann
- Maximilian Zwiebel (ORCID: https://orcid.org/0000-0002-7005-5619)
- Doris Helbig (ORCID: https://orcid.org/0000-0002-5841-4631)
- M. Neulinger (ORCID: https://orcid.org/0000-0001-5406-0402)
- Zeno Fiocco (ORCID: https://orcid.org/0000-0001-8508-6189)
- Takashi K. Satoh (ORCID: https://orcid.org/0000-0002-6064-9253)
- Christiane Pfeiffer (ORCID: https://orcid.org/0000-0001-7770-168X)
- Sonja Senner (ORCID: https://orcid.org/0000-0002-8617-935X)
- Burkhard Summer (ORCID: https://orcid.org/0000-0002-8136-7335)
- Leonie Helene Frommherz (ORCID: https://orcid.org/0000-0003-1384-7844)
- Rubén A. Ferrer (ORCID: https://orcid.org/0000-0002-1704-2069)
- Matthias Mann (ORCID: https://orcid.org/0000-0003-1292-4799)
- Sophia Czell (ORCID: https://orcid.org/0009-0004-2040-9361)
- Irma Kupf (ORCID: https://orcid.org/0009-0004-8331-8467)
- Valerie Glatzel
- Michael Joseph Flaig
- Anna Leonhardt
- Katrin Kerl-French
- Michaela Maurer
- Mohammed Mitwalli
- Annika Sander
- Julia Leding
- Lucas Diedrich (ORCID: https://orcid.org/0009-0007-4884-1422)
Institutions
- Broad Institute (US)
- University of Copenhagen (DK)
- Harvard University (US)
- University of Miami (US)
- University of Zurich (CH)
- Novo Nordisk Foundation (DK)
- LMU Klinikum (DE)
- Massachusetts General Hospital (US)
- University Hospital of Zurich (CH)
- Aesthetic Surgery Center (US)
- München Klinik (DE)
- Max Planck Institute of Biochemistry (DE)
- University Hospital Cologne (DE)
- Johannes Wesling Klinikum Minden (DE)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- British Journal of Dermatology
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1093/bjd/ljag505
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Max-Planck-Gesellschaft
- Ludwig-Maximilians-Universität München